Biotech startup OncoOne picks up Series A
OncoOne, an Austrian biotech startup focused on treating patients with solid tumors, has secured 13 million euros in Series A funding.
OncoOne, an Austrian biotech startup focused on treating patients with solid tumors, has secured 13 million euros in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination